Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

INFORMS study investigators

Research output: Contribution to journalArticleAcademicpeer-review

31 Citations (Scopus)
Original languageEnglish
Pages (from-to)1075-1084
JournalLancet
Volume387
Issue number10023
DOIs
Publication statusPublished - 12 Mar 2016

Cite this